<SEC-DOCUMENT>0001062993-18-003579-index.html : 20180829 <SEC-HEADER>0001062993-18-003579.hdr.sgml : 20180829 <ACCEPTANCE-DATETIME>20180829175113 ACCESSION NUMBER: 0001062993-18-003579 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180823 FILED AS OF DATE: 20180829 DATE AS OF CHANGE: 20180829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gitman Paul CENTRAL INDEX KEY: 0001375378 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 181045119 MAIL ADDRESS: STREET 1: 167 EXECUTIVE DRIVE CITY: MANHASSET HILLS STATE: NY ZIP: 11040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 </SEC-HEADER> <DOCUMENT> <TYPE>4/A <SEQUENCE>1 <FILENAME>form4a.xml <DESCRIPTION>AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES <TEXT> Document 1 - file: form4a.html
Document 1 - RAW XML: form4a.xml
</DOCUMENT> </SEC-DOCUMENT>